Alpha 2.0
Login Register
» Articles » PMID: 19520716

Clinical Efficacy of Temocillin

Overview
Journal J Antimicrob Chemother
Publisher Oxford University Press
Specialty Infectious Diseases
Date 2009 Jun 13
PMID 19520716
Citations 10
Authors
Nidhi D Gupta
Robin E Smith
Indran Balakrishnan
Affiliations
Soon will be listed here.
Citing Articles

Effectiveness of temocillin in treatment of non-urinary tract infections caused by ESBL-producing Enterobacterales and risk factors for failure.

Mamona Kilu C, Menvielle C, Cataldi A, Hamon A, Duran C, Mwanba C JAC Antimicrob Resist. 2024; 6(5):dlae164.

PMID: 39421154 PMC: 11483619. DOI: 10.1093/jacamr/dlae164.

Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective study.

Dinh A, Duran C, Singh S, Tesmoingt C, Bouabdallah L, Hamon A JAC Antimicrob Resist. 2023; 5(1):dlac132.

PMID: 36601547 PMC: 9798080. DOI: 10.1093/jacamr/dlac132.

Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic.

Lupia T, De Benedetto I, Stroffolini G, Di Bella S, Mornese Pinna S, Zerbato V Antibiotics (Basel). 2022; 11(4).

PMID: 35453244 PMC: 9032032. DOI: 10.3390/antibiotics11040493.

Modelled Target Attainment after Temocillin Treatment in Severe Pneumonia: Systemic and Epithelial Lining Fluid Pharmacokinetics of Continuous versus Intermittent Infusions.

Layios N, Visee C, Mistretta V, Denooz R, Maes N, Descy J Antimicrob Agents Chemother. 2022; 66(3):e0205221.

PMID: 35099273 PMC: 8923201. DOI: 10.1128/AAC.02052-21.

Activity of temocillin against third-generation cephalosporin-resistant and bloodstream isolates from a clinical trial.

Stewart A, Henderson A, Bauer M, Paterson D, Harris P JAC Antimicrob Resist. 2022; 4(1):dlab192.

PMID: 34988445 PMC: 8712245. DOI: 10.1093/jacamr/dlab192.